Bringing the fundamentals into focus…
Back to Gyre Therapeutics, Inc.
How Gyre Therapeutics, Inc. stacks up
GYRE · against 454 other Healthcare companies listed in US-listed
Growth
18/ 100
Near the bottom of its peers.
Ranked #388 of 455 · scores higher than 14% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 10–19, including GYRE · Click a bar to see the companies
Why growth scores 18?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
- slower growth in earnings per share: weaker than 91% of peers. Earnings per share growth: -60.0% vs peer median 9.8%
- slower revenue growth over the last year: weaker than 77% of peers. Revenue growth: -3.4% vs peer median 6.1%
- 3-year revenue growth is close to the peer norm. 3-year revenue growth: 4.5% vs peer median 5.8%
Metric by metric
Position: dot = GYRE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GYRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | -3.4% | 11.0% | 19% | 33% | |
| Earnings per share growthHigher is better · 171 reported | -60.0% | 21.2% | 9% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 4.5% | 11.0% | 31% | 33% |
Ranking by growth score
Top 5 and the companies ranked around GYRE| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 382 | 705M USD | 20 | 32 | |
| 386 | 1.2B USD | 19 | 39 | |
| 386 | 966M USD | 19 | 33 | |
| 388 | 21.8B USD | 18 | 32 | |
| 388 | 471M USD | 18 | 21 | |
| 388 | 474M USD | 18 | 46 | |
| 388 | 1.5B USD | 18 | 30 | |
| 388 | 528M USD | 18 | 58 | |
| 393 | 198M USD | 17 | 10 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score